Alpha Tau Medical (NASDAQ:DRTS) Issues Quarterly Earnings Results

Alpha Tau Medical (NASDAQ:DRTS) issued its earnings results on Monday. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.02, Zacks reports.

Alpha Tau Medical Price Performance

Alpha Tau Medical stock traded up $0.31 during mid-day trading on Monday, hitting $3.10. The company’s stock had a trading volume of 121,017 shares, compared to its average volume of 72,237. Alpha Tau Medical has a 52-week low of $1.75 and a 52-week high of $4.39. The firm’s 50 day moving average is $2.63 and its 200 day moving average is $2.90. The company has a market cap of $218.18 million, a PE ratio of -7.21 and a beta of 0.92.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $9.00 price objective on shares of Alpha Tau Medical in a research note on Tuesday, April 29th.

Alpha Tau Medical Company Profile

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.